20.03.2023 • News

Albaugh Acquires Corteva’s Glyphosate Business

US agrochemicals company Albaugh has acquired DuPont spinoff Corteva Agriscience’s straight-goods glyphosate business for an undisclosed sum. The deal is for intangible assets only, such as trade names, registrations, regulatory data, formulations, patents and know-how used worldwide, excluding Argentina.

Albaugh said the purchase will expand its coverage of straight glyphosate dimethylammonium (DMA) salt formulations and registrations globally.

“This latest acquisition of Corteva Agriscience’s glyphosate business is a perfect fit for Albaugh,” said Albaugh’s chief marketing officer Jens Thorsen. “This will expand our direct access to glyphosate markets in areas where we have not previously had a strong presence, including such countries as Chile, Uruguay, Ecuador, Colombia, and Bolivia, as well as supplementing our existing glyphosate offerings in the US, Canada and Brazil.”

Albaugh has previously acquired Corteva’s glyphosate business in Europe, although timing of this earlier deal was not disclosed. 

© Shutterstock/Fotokostic
© Shutterstock/Fotokostic

Last December, Albaugh Europe added Spanish crop protection company Industrias Afrasa to its stable. Stephen Karl, president of Albaugh's Europe, Middle East, and Africa Region said at the time that Afrasa‘s business – mainly focused on Mediterranean crops – complemented Albaugh’s portfolio, with the facilities in Spain building upon the capabilities of its Slovenia facilities to support the company’s rapid growth.

Headquartered in Ankeny, Iowa, Albaugh claims to be the world’s largest privately held supplier of crop protection products.

Author: Elaine Burridge, Freelance Journalist

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read